Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Prostate Cancer”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Not applicableNot Yet RecruitingNCT05707468
What this trial is testing

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Carcinoma
Changhai Hospital 200
Not applicableStudy completedNCT03604211
What this trial is testing

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Who this might be right for
Prostate Cancer RecurrentProstate CancerLymph Node Metastases
Kantonsspital Graubuenden 25
Large-scale testing (Phase 3)Active Not RecruitingNCT03525288
What this trial is testing

PSMA-PET Guided Radiotherapy

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 130
Not applicableWithdrawnNCT03301701
What this trial is testing

Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Hormone Sensitive Oligometastatic Prostate Cancer
Dr. Patrick Cheung
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Not applicableStudy completedNCT02816983
What this trial is testing

SBRT for Oligometastatic Castration-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 89
Large-scale testing (Phase 3)Looking for participantsNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Study completedNCT01558427
What this trial is testing

Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital, Ghent 62
Testing effectiveness (Phase 2)Looking for participantsNCT05560659
What this trial is testing

Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy

Who this might be right for
Oligometastatic Prostate Cancer
Peter MacCallum Cancer Centre, Australia 92
Testing effectiveness (Phase 2)UnknownNCT04031378
What this trial is testing

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Adenocarcinoma
Fundacao Champalimaud 100
Testing effectiveness (Phase 2)Looking for participantsNCT06387056
What this trial is testing

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

Who this might be right for
Locally Advanced Prostate CancerOligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05915442
What this trial is testing

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Catherine Spina 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Not applicableLooking for participantsNCT02971358
What this trial is testing

Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer

Who this might be right for
Locally Advanced and Metastatic Prostate Cancer
Medical University of Vienna 200
Testing effectiveness (Phase 2)Looking for participantsNCT06150417
What this trial is testing

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Who this might be right for
Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate
Case Comprehensive Cancer Center 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07490210
What this trial is testing

Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
Fudan University 300
Not applicableWithdrawnNCT05245435
What this trial is testing

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna
Testing effectiveness (Phase 2)Study completedNCT04992026
What this trial is testing

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Who this might be right for
ProstatectomyOligometastatic Prostate CancerAbiraterone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 130
Not applicableLooking for participantsNCT05183074
What this trial is testing

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

Who this might be right for
Prostate CancerRadiotherapy Side EffectMagnetic Resonance-linac+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Load More Results